• 1
    Bakris GL. CON: blood pressure treatment goal for patients with diabetes should be <130/80 mm Hg. J Clin Hypertens (Greenwich). 2011;13(4):doi: 10.1111/j.1751-7176.2010.00415.x.
  • 2
    ACCORD Study Group, Cushman WC, Evans GW, et al. Effects of intensive blood pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:15751585.
  • 3
    American Diabetes Association. Standards of medical care in diabetes – 2010. Diabetes Care. 2010;33(suppl 1):S11S61.
  • 4
    Patel A, ADVANCE Collaborative Group, MacMahon S, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007;370(9590):829840.
  • 5
    Wright JT Jr, Bakris G, Greene T, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA. 2002;288:24212431.
  • 6
    Gregg EW, Albright AL. The public health response to diabetes – two steps forward, one step back. JAMA. 2009;301(15):15961598.
  • 7
    Zoungas S, de Galan BE, Ninomiya T, et al. Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: new results from the ADVANCE trial. Diabetes Care. 2009;32(11):20682074.